NCT02726750View on ClinicalTrials.gov

Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

December 14, 2015

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Plasma Cell Myeloma
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Laboratory Biomarker Analysis

Correlative studies

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER